It is still at the mice testing stage, but 80% tested had a reversal of diabetes and in other cases it prevented the onset of diabetes. Side effects, etc. will need to be studied as well, but this looks very promising if in fact the drugs can prevent diabetes for many, especially children if their...
Posted to
The Medical Quack .... by Barbara Duck
on 11-19-2008
Filed under: Medically Related, Pharma/FDA News, personalized medicine, healthcare, Cancer, Diabetes, R and D, San Francisco University of California
It is here but evolving slower than what all of us might like to see, and in many areas it is still so much of a “Science” but as developments occur through biotech we are seeing some amazing results. There’s also the bridging of the gap with bringing genomics to the point of care, as physicians...
Posted to
The Medical Quack .... by Barbara Duck
on 10-26-2008
Filed under: Medically Related, Technology, Pharma/FDA News, personalized medicine, healthcare, Pharma, Biotech, Cancer, tumors, Genentech, Herceptin, cancer vaccine
One thing that comes to mind is what a waste of talent here. Series of events lead up to where he is today, but started when he ran out of money for his research related to the GFP gene and cancer. “Researchers worldwide now use GFP to track development of brain cells, the growth of tumors...
Posted to
The Medical Quack .... by Barbara Duck
on 10-14-2008
Filed under: Medically Related, Technology, Pharma/FDA News, personalized medicine, Genomics, healthcare, Cancer, R and D, GFP Gene, Nobel Prize
As the article states, you don’t need marketing for cancer drugs, as the need is unfortunately already there, thus marketing for cancer drugs does not necessarily carry the same sales expense as do other drugs. We have all seen the “tiered plans” on what level drugs are listed with insurance coverage...
Posted to
The Medical Quack .... by Barbara Duck
on 10-13-2008
Filed under: Medically Related, Insurance, Other Items of Interest, My Commentaries, personalized medicine, Genomics, health insurance, Pharma, Prescriptions, Cancer, R and D, Science 2.0
This is a very small clinical trial of 12 individuals with cancer, and any related treatment plans are still quite a few miles away, but more work with personalized medicine in progress. BD This week, University of Michigan scientists will begin a phase 1 clinical trial for the treatment...
If you want to do some reading up on the topic, this site may offer some help, along with the upcoming conference to be held here in the Los Angeles area in October. As posted recently there are plans for many of the service companies, such as 23andMe , Navigenics , DeCode, LabCorp , and perhaps...
Posted to
The Medical Quack .... by Barbara Duck
on 09-11-2008
Filed under: Medically Related, Pharma/FDA News, My Commentaries, Physician, personalized medicine, Genomics, Cancer, Pharmacogenomics, Patients, Genonimic Testing, Human Genome Project, Genomic Counseling, Lab Tests
This is somewhat the first step in identifying the gene pRb2/p130, which has very good possibilities to help determine the most beneficial course of chemotherapy and/or radiation treatments following surgery, something every doctor and patient could value, more personalized medicine research and development...